Alemtuzumab for refractory celiac disease
- PMID: 17005966
- DOI: 10.1056/NEJMc061784
Alemtuzumab for refractory celiac disease
Comment on
-
Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma.N Engl J Med. 2006 Jun 8;354(23):2514-5. doi: 10.1056/NEJMc053129. N Engl J Med. 2006. PMID: 16760460 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical